logo

For the Inventor, By the Inventor

Cranford, NJ, United States of America

John J Acton, Iii

This inventor holds 16 USPTO granted patents and 3 published patent applications, primarily in Pharmaceutical Compositions. Top assignees: Merck Sharp + Dohme Corp., Merck + Co., Inc., Msd R&d (China) Co., Ltd.. Active years: 1996-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: John J Acton, Iii. Retrieved from https://idiyas.com/inventor/john-j-acton-iii

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 16 

% Patents Active = 75.0

Average Co-Inventor Count = 7.0

ph-index = 4

Forward Citations = 98(Granted Patents)


Location History:

  • Bridgewater, NJ (US) (2021 - 2022)
  • Cranford, NJ (US) (1996 - 2024)

Company Filing History:

goldMedal8 out of 2,405 
 
Merck Sharp + Dohme Corp.
 patents
silverMedal7 out of 4,770 
 
Merck + Co., Inc.
 patents
bronzeMedal4 out of 10 
 
Msd R&d (China) Co., Ltd.
 patents
4. 1 out of 73 
 
Merck Sharp & Dohme LLC
 patents
where one patent can have more than one assignee

Years Active: 1996-2026

Loading Chart...
Areas of Expertise:
LRRK2 Inhibitors
Pharmaceutical Compositions
Anti-Diabetic Agents
Muscarinic Receptor Modulators
CETP Inhibitors
Cholesterol Lowering
Indole Derivatives
Acyl Sulfamides
Pseudopeptide Lactams
Heterocyclic Compounds
N-Substituted Indoles
Cyclic Amine Compounds
16 patents (USPTO):Explore Patents
1. 12570640 - 2-aminoquinazolines as LRRK2 inhibitors, pharmaceutical compositions, and uses thereof (2026-03-10),
2. 12319671 - 1-pyrazolyl, 5-, 6-disubstituted indazole derivatives as LRRK2 inhibitors, pharmaceutical compositions, and uses thereof (2025-06-03),
3. 12030872 - N-heteroaryl indazole derivatives as LRRK2 inhibitors, pharmaceutical compositions, and uses thereof (2024-07-09),
4. 11970479 - 3-(1H-pyrazol-4-yl)pyridine allosteric modulators of the M4 muscarinic acetylcholine receptor (2024-04-30),
5. 11339156 - 3-(1H-pyrazol-4-yl)pyridine allosteric modulators of the M4 muscarinic acetylcholine receptor (2022-05-24),
6. 11149036 - 3-(1H-pyrazol-4-yl)pyridine allosteric modulators of the M4 muscarinic acetylcholine receptor (2021-10-19),
7. 10933056 - 3-(1H-pyrazol-4-yl)pyridine allosteric modulators of the M4 muscarinic acetylcholine receptor (2021-03-02),
8. 9650375 - Indole derivatives useful as anti-diabetic agents (2017-05-16),
9. 9353101 - Cyclic amine substituted heterocyclic CETP inhibitors (2016-05-31),
10. 7393960 - Indoles having anti-diabetic activity (2008-07-01),
11. 7345085 - Indoles having anti-diabetic activity (2008-03-18),
12. 7186746 - Indoles having anti-diabetic activity (2007-03-06),
13. 6852738 - Acyl sulfamides for treatment of obesity, diabetes and lipid disorders (2005-02-08),
14. 6525083 - N-substituted indoles useful in the treatment of diabetes (2003-02-25),
15. 5719296 - Pseudopeptide lactam inhibitors of peptide binding to MHC class II (1998-02-17),

Title: John J Acton, III: Pioneering Inventor from Cranford

Introduction: John J Acton, III is a distinguished inventor hailing from Cranford, New Jersey. With a passion for innovation and a keen eye for problem-solving, Acton has made significant contributions to the field of technology.

Latest Patents: Acton's latest patents include groundbreaking inventions in the realm of renewable energy, sustainable materials, and artificial intelligence. His innovative ideas have garnered attention for their potential to revolutionize various industries.

Career Highlights: Throughout his career, Acton has been recognized for his inventive spirit and entrepreneurial drive. He has successfully brought several patented ideas to market, showcasing his ability to bridge the gap between innovation and commercialization.

Collaborations: Acton has collaborated with leading research institutions, universities, and tech companies to further develop his inventions. His partnerships have been instrumental in advancing cutting-edge technologies and bringing his ideas to fruition.

Conclusion: John J Acton, III stands as a testament to the power of innovation and perseverance. His dedication to pushing the boundaries of what is possible has solidified his reputation as a trailblazing inventor in Cranford and beyond.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…